Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?
João Sérgio Neves, Faı̈ez Zannad, Javed Butler, Milton Packer, João Pedro Ferreira
Topics & Concepts
MedicineGlucagon-like peptide 1 receptorInternal medicineReceptorAgonistDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerHyperglycemia and glycemic control in critically ill and hospitalized patients